Key Takeaways
- • Corporate venture capital (CVC) transactions represent $5 billion of the $138 billion secondary market for VC stakes, and this portion is expanding as institutional investors increasingly participate in secondary sales to generate liquidity.
- • The VC secondary market is experiencing accelerating activity due to a backlog of IPOs, subdued M&A conditions, and macroeconomic pressures including the Trump administration's tariffs announced in April 2025, which have heightened investor urgency to offload positions.
- • Successful secondary stake sales require strategic timing (coordinating with startup funding rounds), transparent communication with stakeholders about sale intentions, favorable contractual terms, and navigation of pre-existing company restrictions such as rights of first refusal (ROFR).
- • Secondary market sales allow corporate investors to recycle capital into new deals, de-risk concentrated portfolios, and lock in valuation gains before market conditions shift—benefits that are becoming increasingly critical as traditional exit pathways slow.
Summary
The secondary market for venture capital stakes has become an increasingly mainstream liquidity channel for corporate investors, though the sales process typically requires months to complete and careful navigation of contractual and procedural complexities. According to Davorin Kuchan, managing partner of FreeRun Ventures, CVC transactions currently represent $5 billion of a $138 billion total secondary market, reflecting a meaningful but still-developing portion of overall activity. The broader market is expected to accelerate further, driven by a significant backlog of initial public offerings and a weakened M&A environment that has forced institutional and corporate investors to seek alternative liquidity channels.
Macroeconomic conditions have intensified demand for secondary sales in recent months. The Trump administration's so-called Liberation Day tariffs, first announced in April 2025, have created additional market volatility and investor uncertainty. "Since Liberation Day, the level of interest to get liquidity has accelerated meaningfully," according to Olav Ostin, managing partner at TempoCap, a secondary market fund. This urgency has been compounded by investors facing cash deadlines or revised expectations around traditional exit timelines, amplifying both opportunity and execution risk in the secondary market.
Global Ventures Collective (GCV) convened a webinar addressing best practices for corporate investors executing secondary sales. The guidance emphasized six core recommendations: timing sales to coincide with startup funding rounds when company valuations are fresh and investor appetite is highest; eliminating or clarifying pre-existing contractual restrictions such as rights of first refusal; establishing favorable deal terms upfront to avoid protracted negotiations; communicating transparently with relevant stakeholders about sale intentions; understanding the precise nature and rights associated with holdings; and securing necessary company and legal approvals before engaging potential buyers. These procedural disciplines reduce transaction friction and execution risk in what remains a less liquid market than public equities or M&A for mature companies.
For corporate investors, secondary sales serve multiple portfolio objectives: recycling capital into new deal flow, reducing concentration risk in mature or underperforming holdings, and locking in valuation gains before broader market deterioration. These dynamics have elevated the strategic importance of secondary market expertise within corporate venture arms and family offices managing concentrated private equity exposure.
Macroeconomic conditions have intensified demand for secondary sales in recent months. The Trump administration's so-called Liberation Day tariffs, first announced in April 2025, have created additional market volatility and investor uncertainty. "Since Liberation Day, the level of interest to get liquidity has accelerated meaningfully," according to Olav Ostin, managing partner at TempoCap, a secondary market fund. This urgency has been compounded by investors facing cash deadlines or revised expectations around traditional exit timelines, amplifying both opportunity and execution risk in the secondary market.
Global Ventures Collective (GCV) convened a webinar addressing best practices for corporate investors executing secondary sales. The guidance emphasized six core recommendations: timing sales to coincide with startup funding rounds when company valuations are fresh and investor appetite is highest; eliminating or clarifying pre-existing contractual restrictions such as rights of first refusal; establishing favorable deal terms upfront to avoid protracted negotiations; communicating transparently with relevant stakeholders about sale intentions; understanding the precise nature and rights associated with holdings; and securing necessary company and legal approvals before engaging potential buyers. These procedural disciplines reduce transaction friction and execution risk in what remains a less liquid market than public equities or M&A for mature companies.
For corporate investors, secondary sales serve multiple portfolio objectives: recycling capital into new deal flow, reducing concentration risk in mature or underperforming holdings, and locking in valuation gains before broader market deterioration. These dynamics have elevated the strategic importance of secondary market expertise within corporate venture arms and family offices managing concentrated private equity exposure.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.